Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

What Happened? Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 3.7% in the afternoon session after ...

Bristol-Myers Squibb (BMY) has quietly staged a comeback, with the stock up about 17% over the past month and roughly 23% in the past 3 months, catching the attention of value focused investors. See ...

Bristol Myers Squibb (BMY) is undervalued and poised for growth, with strong dividends and robust financials. Read here for ...

Share price of Bristol Myers Squibb (BMY) touched a 52-week low of $42.96 on July 31, post its second-quarter earnings release. The stock has recovered 6.7% since then and is currently trading at ...

Bristol-Myers Squibb's key drugs are losing patent protection, while more recently launched drugs are struggling to meet peak ...

Bristol Myers Squibb Company BMY has been performing well recently. Shares of this biotech giant have gained 13.1% in the ...

Bristol-Myers Squibb Company (NYSE:BMY) presents a measured balance between risk and reward. The stock offers a 4.6% dividend ...

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Achievers List. Several of the largest US and European drugmakers struck agreements with President Donald Trump ...